Market revenue in 2023 | USD 40,959.3 million |
Market revenue in 2030 | USD 60,647.7 million |
Growth rate | 5.8% (CAGR from 2023 to 2030) |
Largest segment | Phase iii |
Fastest growing segment | Phase I |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Phase I, Phase II, Phase III, Phase IV |
Key market players worldwide | Thermo Fisher Scientific Inc, Icon PLC, Charles River Laboratories International Inc, IQVIA Holdings Inc, Syneos Health, SGS AG, PAREXEL, Wuxi AppTec Co Ltd, Labcorp Holdings Inc, Eli Lilly and Co, Novo Nordisk A/S ADR, Pfizer Inc, Caidya |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to clinical trials market will help companies and investors design strategic landscapes.
Phase iii was the largest segment with a revenue share of 53.51% in 2023. Horizon Databook has segmented the North America clinical trials market based on phase i, phase ii, phase iii, phase iv covering the revenue growth of each sub-segment from 2018 to 2030.
The U.S. is the largest market for clinical trials as the country spends the highest healthcare per capita, and an increased number of clinical trials have been undertaken to seek FDA approval. In addition, many companies have shifted their focus to outsourcing emerging market players due to the increasing regulatory requirements and long approval timelines.
This has led to the majority of outsourcing activities in North America. High research cost further prompts companies to outsource clinical trials to other research organizations. Several companies, such as Parexel International Corporation and Charles River Laboratory, are present in North America.
The regional presence of these companies encourages the collaboration of technology and data management, allowing better data accessibility and trial monitoring, fueling the market demand. Moreover, the increasing number of product pipelines is encouraging big pharmaceutical & biopharmaceutical and medical device companies to invest in clinical trials R&D services.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America clinical trials market , including forecasts for subscribers. This continent databook contains high-level insights into North America clinical trials market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account